Enhanced oral bioavailability and sustained delivery of glimepiride via niosomal encapsulation: in-vitro characterization and in-vivo evaluation

References

• WHO G. Guidelines for drinking-water quality. Vol. 216. Geneva: World Health Organization; 2011. p. 303–4.
   Google Scholar
• Kaul K, Tarr JM, Ahmad SI, Kohner EM, Chibber R. Introduction to diabetes mellitus. Diabetes. New York: Springer; 2013. p. 1–11.
   Google Scholar
• LaMonte MJ, Blair SN, Church TS. Physical activity and diabetes prevention. J Appl Physiol 2005;99:1205–13.
   PubMed Web of Science ®Google Scholar
• Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy a consensus statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care 2006;29:1963–72.
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Hirose T, Asakawa H, et al. Efficacy of glimepiride in type 2 diabetic patients treated with glibenclamide. Diabetes Res Clin Pract 2004;66:S129–32.
   PubMed Web of Science ®Google Scholar
• Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA 2002;287:360–72.
   PubMed Web of Science ®Google Scholar
• Ahmed TA, Khalid M, Aljaeid BM, et al. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: preparation, characterization, in vitro, ex vivo and clinical evaluation. Int J Pharm 2016;500:245–54.
   PubMed Web of Science ®Google Scholar
• Löbenberg R, Amidon GL. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm 2000;50:3–12.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernas H, shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of invitro drug product dissolution and invivo bioavailability. Pharm Res 1995;12:413–20.
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Javadzadeh Y, Siahi-Shadbad MR, Barzegar-Jalali M. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J Pharm Pharm Sci 2005;8:18–25.
   PubMed Web of Science ®Google Scholar
• Chaudhari MD, Sonawane RO, Zawar LA, et al. Solubility and dissolution enhancement of poorly water soluble Glimepiride by using solid dispersion technique. Int J Pharm Pharm Sci 2012;4:534–9.
   Google Scholar
• Profozić V, Metelko Ž. Pharmacological properties of glimepiride: rationale for clinical use in type 2 diabetes. Dis Manage Health Outcomes 1998;4:29–41.
   Google Scholar
• Ikegami H, Shima K, Tanaka A, et al. Interindividual variation in the absorption of glibenclamide in man. Acta Endocrinologica 1986;111:528–32.
   PubMedGoogle Scholar
• Yadav JD, Kulkarni PR, Vaidya KA, Shelke GT. Niosomes: a review. J Pharm Res 2011;4:632–6.
   Google Scholar
• Karim KM, Mandal AS, Biswas N, et al. Niosome: a future of targeted drug delivery systems. J Adv Pharm Technol Res 2010;1:374.
   PubMedGoogle Scholar
• Shirsand SB, Para MS, Nagendrakumar D, et al. Formulation and evaluation of Ketoconazole niosomal gel drug delivery system. Int J Pharm Investig 2012;2:201.
   PubMedGoogle Scholar
• Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release 2014;185:22–36.
   PubMed Web of Science ®Google Scholar
• Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27:S5–10.
   PubMedGoogle Scholar
• Chandra SY, Venu V, Jaganathan K, et al. Formulation and in-vitro evaluation of sustained release matrix tablets of glimepiride by using natural gums as release modifiers. J Global Trends Pharm Sci 2011;2:394–403.
   Google Scholar
• Azeem A, Anwer MK, Talegaonkar S. Niosomes in sustained and targeted drug delivery: some recent advances. J Drug Target 2009;17:671–89.
   PubMed Web of Science ®Google Scholar
• Arunothayanun P, Turton JA, Uchegbu IF, Florence AT. Preparation and in vitro/in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical/tubular niosomes. J Pharm Sci 1999;88:34–8.
   PubMed Web of Science ®Google Scholar
• Namedeo A, Jain NK. Niosomal delivery of 5-fluorouracil. J Microencapsul 1999;16:731–40.
   PubMed Web of Science ®Google Scholar
• Perrie Y, Barralet J, McNeil S, Vangala A. Surfactant vesicle-mediated delivery of DNA vaccines via the subcutaneous route. Int J Pharm 2004;284:31–41.
   PubMed Web of Science ®Google Scholar
• Abdelkader H, Ismail S, Kamal A, Alany RG. Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci 2011;100:1833–46.
   PubMed Web of Science ®Google Scholar
• Bayindir ZS, Y N. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 2010;99:2049–60.
   PubMed Web of Science ®Google Scholar
• Akhter S, Kushwaha S, Warsi MH, et al. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir. Drug Dev Ind Pharm 2012;38:84–92.
   PubMed Web of Science ®Google Scholar
• Muzzalupo R, Tavano L, Cassano R, et al. A new approach for the evaluation of niosomes as effective transdermal drug delivery systems. Eur J Pharm Biopharm 2011;79:28–35.
   PubMed Web of Science ®Google Scholar
• Mohawed O, El-Ashmoony M. Niosome-encapsulated clomipramine for transdermal controlled delivery. IJPPS 2014;6:567–75.
   Google Scholar
• Ning M, Guo Y, Pan H, et al. Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: studies in rats. Drug Deliv 2005;12:399–407.
   PubMed Web of Science ®Google Scholar
• Baillie AJ, Florence AT, Hume LR, et al. The preparation and properties of niosomes-non-ionic surfactant vesicles. J Pharm Pharmacol 1985;37:863–8.
   PubMed Web of Science ®Google Scholar
• Baillie AJ, Coombs GH, Dolan TF, Laurie J. Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate. J Pharm Pharmacol 1986;38:502–5.
   PubMed Web of Science ®Google Scholar
• Bhaskaran S, Lakshmi PK. Comparative evaluation of niosome formulations prepared by different techniques. Acta Pharma Sci 2009;51:27–32.
   Google Scholar
• Uchegbu FI, Vyas PS. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 1998;33:172.
   Google Scholar
• Jigar V, Puja V, Krutika S. Formulation and evaluation of topical niosomal gel of erythromycin. IJPPS 2011;3:123–6.
   Google Scholar
• El-Ridy MS, Abdelbary A, Essam T, et al. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. Drug Develop Indus Pharm 2011;37:1491–508.
   PubMed Web of Science ®Google Scholar
• Law SL, Lo WY, Lin M. Increase of liposome stability by incorporation of bovine serum albumin. Drug Dev Ind Pharm 1994;20:1411–23.
   Web of Science ®Google Scholar
• Fang JY, Hong CT, Chiu WT, Wang YY. Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 2001;219:61–72.
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonization. Vaidation of analytical procedures: text and methodology. 2005;Q2 (R1).
   Google Scholar
• Aggarwal D, Kaur IP. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharm 2005;290:155–9.
   PubMed Web of Science ®Google Scholar
• Gupta PK, Hung CT, Perrier DG. Quantitation of the release of doxorubicin from colloidal dosage forms using dynamic dialysis. J Pharm Sci 1987;76:141–5.
   PubMed Web of Science ®Google Scholar
• Yadav SK, Mishra S, Mishra B. Eudragit-based nanosuspension of poorly water-soluble drug: formulation and in vitro-in vivo evaluation. AAPS PharmSciTech 2012;13:1031–44.
   PubMed Web of Science ®Google Scholar
• Hasan AA, Madkor H, Wageh S. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system. Drug Deliv 2013;20:120–6.
   PubMed Web of Science ®Google Scholar
• Saini N, Sodhi RK, Bajaj L, et al. Intravaginal administration of metformin hydrochloride loaded cationic niosomes amalgamated with thermosensitive gel for the treatment of polycystic ovary syndrome: In vitro and in vivo studies. Colloids Surf B Biointerfaces 2016;144:161–9.
   PubMed Web of Science ®Google Scholar
• Venkatesh B, Indira S, Srinivas P. Formulation and evaluation of glimepiride oral capsules. Int J Pharm Sci Invent 2014;10: 1–13.
   Google Scholar
• Bhulli N, Sharma A. Preparation of Novel vesicular carrier ethosomes with glimepiride and their investigation of permeability. Int J Therap Appl 2012;2:1–10.
   Google Scholar
• Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol 1975;27:48–9.
   PubMed Web of Science ®Google Scholar
• ElMeshad AN, Mohsen AM. Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle. Drug Deliv 2016;23:2115–23.
   PubMed Web of Science ®Google Scholar
• Najib N, Suleiman MS. The kinetics of drug release from ethylcellulose solid dispersions. Drug Dev Ind Pharm 1985;11:2169–81.
   Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained-action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145–9.
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25–35.
   Web of Science ®Google Scholar
• Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 2010;67:217–23.
   PubMed Web of Science ®Google Scholar
• De Souza DM, Medeiros AC, Santos JO, Lima MCM, de Aquino Si A. Spontaneous alveolar bone loss development by alloxan-induced diabetes mellitus in rats. Int J Adv Med Sci 2015;3:37–44.
   Google Scholar
• Khan MSS, Hussain AI, Rahim MA, et al. The study of hypoglycemic effect of microencapsulated glimepiride in long evans rats. Int J Adv Pharm 2013;1:16–21.
   Google Scholar
• Rheney CC, Kirk JK. Performance of three blood glucose meters. Ann Pharmacother 2000;34:317–21.
   PubMed Web of Science ®Google Scholar
• Mohd AB, Sanka K, Bandi S, et al. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of glimepiride: development and antidiabetic activity in albino rabbits. Drug Deliv 2015;22:499–508.
   PubMed Web of Science ®Google Scholar
• Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy. Int J Pharm 2006;320:53–7.
   PubMed Web of Science ®Google Scholar
• Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (span-20, span-40, span-60 and span-80) and a sorbitan triester (span-85). Int J Pharm 1994;105:1–6.
   Web of Science ®Google Scholar
• Sambhakar S, Singh B, Paliwal SK, Mishra PR. Niosomes as a potential carrier for controlled release od cefuroxime axetil. Asian J Biochem Pharm Res 2011;11:126–36.
   Google Scholar
• Manosroi A, Wongtrakul P, Manosroi J, et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B Biointerfaces 2003;30:129–38.
   Web of Science ®Google Scholar
• El-Ridy MS, Badawi AA, Safar MM, Mohsen AM. Niosomes as a novel pharmaceutical formulation encapsulating the hepatoprotective drug silymarin. IJPPS 2012;4:549–59.
   Google Scholar
• Tavano L, Aiello R, Ioele G, et al. Niosomes from glucuronic acid-based surfactant as new carriers for cancer therapy: preparation, characterization and biological properties. Colloids Surf B Biointerfaces 2014;118:7–13.
   PubMed Web of Science ®Google Scholar
• Muzzalupo R, Tavano L, La Mesa C. Alkyl glucopyranoside-based niosomes containing methotrexate for pharmaceutical applications: evaluation of physico-chemical and biological properties. Int J Pharm 2013;458:224–9.
   PubMed Web of Science ®Google Scholar
• Mahale NB, Thakkar PD, Mali RG, et al. Niosomes: novel sustained release nonionic stable vesicular systems: an overview. Adv Colloid Interface Sci 2012;183:46–54.
   PubMed Web of Science ®Google Scholar
• Ruckmani K, Sankar V. Formulation and optimization of Zidovudine niosomes. AAPS PharmSciTech 2010;11:1119–27.
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Florence AT. Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Colloid Interface Sci 1995;58:1–55.
   Web of Science ®Google Scholar
• Mclntosh TJ. The effect of cholesterol content on the structure of phosphatidylcholine bilayers. Biochim Biophys Acta 1978;51:43–58.
   Web of Science ®Google Scholar
• Sankhyan A, Pawar PK. Metformin loaded non-ionic surfactant vesicles: optimization of formulation, effect of process variables and characterization. DARU J Pharm Sci 2013;21:1.
   Web of Science ®Google Scholar
• Centis V, Vermette P. Physico-chemical properties and cytotoxicity assessment of PEG-modified liposomes containing human hemoglobin. Colloids Surf B Biointerfaces 2008;65:239–46.
   PubMed Web of Science ®Google Scholar
• Shakeel F, Baboota S, Ahuja A, et al. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech 2007;8:191–9.
   Web of Science ®Google Scholar
• Hanaor D, Michelazzi M, Leonelli C, Sorrell CC. The effects of carboxylic acids on the aqueous dispersion and electrophoretic deposition of ZrO2. J Eur Ceram Soc 2012;32:235–44.
   Web of Science ®Google Scholar
• Udupa N, Chandraprakash KS, Umadevi P, Pillai GK. Formulation and evaluation of methotrexate niosomes. Drug Dev Ind Pharm 1993;19:1331–42.
   Web of Science ®Google Scholar
• Parthasarathi G, Udupa N, Umadevi P, Pillai G. Niosome encapsulated of vincristine sulfate: improved anticancer activity with reduced toxicity in mice. J Drug Target 1994;2:173–82.
   PubMed Web of Science ®Google Scholar
• Haider MD, Kanoujia J, Tripathi CB, et al. Piogli loaded vesicular carriers for anti-diabetic activity: development and optimization as per central composite design. J Pharm Sci Pharm 2015;2:11–20.
   Google Scholar
• Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 2008;361:104–11.
   PubMed Web of Science ®Google Scholar
• Singh G, Dwivedi H, Saraf SK, Saraf SA. Niosomal delivery of isoniazid-development and characterization. Tropic J Pharmaceut Res 2011;10:203–210.
   Web of Science ®Google Scholar
• Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001;50:537–46.
   PubMed Web of Science ®Google Scholar